S.V. Kulyk

Statistics

Publications

Citations

128

H-Index

Active since

2012

Affiliations

Kyiv City Clinical Oncology Center(Current)

S.V. Kulyk is an author at Kyiv City Clinical Oncology Center specializing in antineoplastic drug classes, cyclin-dependent kinase 4 inhibitors, and hormonal cancer therapy.

ORCID

Publications per year

2012–2012

Publications

Abstract S1-6: Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (BC)

RS Finn, JP Crown, István Láng et al. · Cancer Research · 2012 · 128 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1